Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Pancreatic Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanghai General Hospital, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Jiang Long, MD)